|
|
| Line 1: |
Line 1: |
| __NOTOC__
| | #REDIRECT [[Ticlopidine#Adult Indications and Dosage]] |
| {{Ticlopidine}}
| |
| {{CMG}}; {{AE}} {{AZ}}
| |
|
| |
|
| ==Dosage And Administration==
| | [[Category: Cardiovascular Drugs]] |
| | | [[Category: Drug]] |
| ===Stroke===
| | [[Category:Antiplatelet drugs]] |
| | |
| The recommended dose of ticlopidine hydrochloride is '''250 mg bid taken with food'''. Other doses have not been studied in controlled trials for these indications.
| |
| | |
| ===Coronary Artery Stenting===
| |
| | |
| The recommended dose of ticlopidine hydrochloride is '''250 mg bid taken with food''' together with antiplatelet doses of aspirin for up to 30 days of therapy following successful stent implantation.<ref name="dailymed.nlm.nih.gov">{{Cite web | last = | first = | title = TICLOPIDINE HYDROCHLORIDE TABLET, FILM COATED [APOTEX CORP.] | url =http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=707127cb-cdcd-81b0-274d-3c11fefa6824 | publisher = | date = | accessdate = }}</ref>
| |
| | |
| ==References==
| |
| {{Reflist}}
| |
| | |
| {{FDA}}
| |
| | |
| [[Category:Drugs]] | |